p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes

Jaime DeSantiago1, Dan J Bare1, Lei Xiao2

  • 1Center for Cardiovascular Research, University of Illinois at Chicago, 840 S. Wood Street, Chicago, IL 60612, USA; Department of Medicine, Section of Cardiology, University of Illinois at Chicago, 840 S. Wood Street, Chicago, IL 60612, USA.

Insights

p21-activated kinase (Pak1) deficiency in heart cells increases calcium overload and arrhythmias during ischemia. Pak1 normally suppresses reactive oxygen species (ROS) and sodium-calcium exchanger (NCX) activity, preventing these issues.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Physiology

Background:

  • Ischemic conditions reduce p21-activated kinase (Pak1) activity, leading to increased cardiac arrhythmias.
  • Arrhythmias during ischemia are linked to altered cellular ion balance and calcium handling.
  • Pak1's role in regulating these changes is not fully understood.

Purpose of the Study:

  • To investigate the mechanism by which Pak1 influences arrhythmic activity generation during simulated ischemia.
  • To determine Pak1's role in regulating calcium handling and reactive oxygen species (ROS) production in ventricular myocytes (VMs).

Main Methods:

  • Utilized isolated mouse ventricular myocytes (VMs) genetically deficient for Pak1 (Pak1(-/-)).
  • Simulated ischemic conditions and measured intracellular calcium ([Ca(2+)]i) transients, ROS levels, and sodium-calcium exchanger (NCX) activity.
  • Employed pharmacological inhibitors for NCX, ROS, and Rac1, as well as genetic models for NADPH oxidase 2 (NOX2).

Main Results:

  • Pak1(-/-) VMs showed exaggerated intracellular calcium ([Ca(2+)]i) overload and spontaneous calcium release events during simulated ischemia.
  • This calcium overload was suppressed by NCX blockers, ROS scavengers, and Rac1 inhibitors.
  • Pak1 deficiency led to increased cellular ROS production, dependent on NADPH oxidase 2 (NOX2).
  • Pak1(-/-) VMs exhibited enhanced NCX activity, driven by NOX2-induced ROS.

Conclusions:

  • Pak1 acts as a critical negative regulator of NOX2-dependent ROS production in cardiac myocytes.
  • Reduced Pak1 activity promotes ROS-mediated NCX stimulation, leading to calcium overload.
  • This mechanism predisposes ventricular myocytes to arrhythmias under ischemic conditions, even before significant excitation-contraction coupling changes are evident.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K